Gensure

used to qualitatively detect IgG and IgM antibodies of the novel coronavirus in human serum, plasma or whole blood in vitro.

rapid acquisition of test results within 15 minutes, and compatibility with the detection of more than 60 immune markers, not only suitable for the rapid diagnosis of critical illnesses at the bedside in large and medium-sized hospital, but also suitable for the quantitative analysis of immunological tests in the laboratory of small and medium-sized hospitals. It is also suitable for the needs of primary hospitals to realize the detection of common diseases. By the beginning of 2020, the company has obtained 23 NMPA certified medical device certificates, and has become one of the enterprises with the most complete POCT product line in China.